Robotic surgeries enhance surgical precision and dexterity, significantly reducing patient trauma, post-operative pain, and recovery times, leading to shorter hospital stays. As robotic surgery becomes the standard for various procedures, its global market is set to quadruple, reaching approximately $36 billion by 2032.
Realising the potential in this sector, several startups specialise in this category. In recent times, we have seen Neocis raise funding for robotic dental implant surgeries. Also, ForSight Robotics raised funding for robotic eye surgeries.
Yet another startup operating in this segment is Nami Surgical, headquartered in Glasgow, Scotland. It aims to transform the robotic-assisted surgery market with an ultrasonic platform.
Raises $4M funding
In a recent development, Nami Surgical raised $4 million in investment and grant funding. Scottish impact investment firm Eos Advisory (Eos) led the seed round of $3.1 million alongside the Investment Fund for Scotland, which is managed by UK private equity firm Maven and delivered by British Business Bank, Scottish Enterprise, and SIS Ventures.
In addition to this, the company was awarded a grant from Innovate UK, the United Kingdom’s national innovation agency, which backed SökerData and Cogitat.
Nami Surgical intends to deploy the funds to expand its operations and R&D sector.
Develops miniature ultrasonic surgical devices
Established by Nico Fenu and Dr. Rebecca Cleary in 2022, Nami Surgical is a spin-out technology company from the University of Glasgow. It develops miniaturised ultrasonic medical devices for surgical applications. It supports medical device companies to deliver innovation in ultrasonic surgery. Recently, the company has introduced a high-performance, miniaturised ultrasonic scalpel, overcoming significant barriers in robotic-assisted surgery.
Traditionally used in laparoscopic procedures, ultrasonic scalpels have been too large for effective use in robotic surgery until now. However, Nami Surgical has set a new benchmark in surgical care with its technology that enables the use of ultrasonic scalpels in robotic surgeries.
Nami Surgical’s CEO and Co-founder Nico Fenu said: “Robot-assisted surgery has become increasingly popular in recent years and is now widely used in various surgical procedures including urology, gynaecology, and colorectal. We have pilot programmes running with healthcare and medical device groups worldwide, including in the United States, and we now look forward to the commercialisation phase with the support of our new investors.”
The company is chaired by experienced life science and medtech NXD Albert Nicholl. Albert Nicholl said: “We have a huge opportunity ahead of us and a fast route to market with the first product from the platform.”
Nico Fenu added: “We are committed to close collaboration with clinicians and companies in the industry to translate their needs into novel devices that not only improve patient outcomes but also drive ultrasonic surgery to the next level. It’s an exciting time for us, and we are just getting started.”
